Clinical Trials for Chong Kun Dang Pharmaceutical

Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors

Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea

A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants

Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981

A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia

A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)

A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants

Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A

To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers

Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes

Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance

MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

Efficacy and Safety of Telmisartan Compared With Losartan

Efficacy and Safety of EsoDuo®

SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study